» Articles » PMID: 37091337

Key Aspects for Conception and Construction of Co-culture Models of Tumor-stroma Interactions

Overview
Date 2023 Apr 24
PMID 37091337
Authors
Affiliations
Soon will be listed here.
Abstract

The tumor microenvironment is crucial in the initiation and progression of cancers. The interplay between cancer cells and the surrounding stroma shapes the tumor biology and dictates the response to cancer therapies. Consequently, a better understanding of the interactions between cancer cells and different components of the tumor microenvironment will drive progress in developing novel, effective, treatment strategies. Co-cultures can be used to study various aspects of these interactions in detail. This includes studies of paracrine relationships between cancer cells and stromal cells such as fibroblasts, endothelial cells, and immune cells, as well as the influence of physical and mechanical interactions with the extracellular matrix of the tumor microenvironment. The development of novel co-culture models to study the tumor microenvironment has progressed rapidly over recent years. Many of these models have already been shown to be powerful tools for further understanding of the pathophysiological role of the stroma and provide mechanistic insights into tumor-stromal interactions. Here we give a structured overview of different co-culture models that have been established to study tumor-stromal interactions and what we have learnt from these models. We also introduce a set of guidelines for generating and reporting co-culture experiments to facilitate experimental robustness and reproducibility.

Citing Articles

Recent Advances in Barnacle-Inspired Biomaterials in the Field of Biomedical Research.

Min T, Zhang Z, Chen L, Li J Materials (Basel). 2025; 18(3).

PMID: 39942168 PMC: 11818484. DOI: 10.3390/ma18030502.


Facilitation of Tumor Stroma-Targeted Therapy: Model Difficulty and Co-Culture Organoid Method.

Feng Q, Shan X, Yau V, Cai Z, Xie S Pharmaceuticals (Basel). 2025; 18(1).

PMID: 39861125 PMC: 11769033. DOI: 10.3390/ph18010062.


Harnessing 3D models to uncover the mechanisms driving infectious and inflammatory disease in the intestine.

Micati D, Hlavca S, Chan W, Abud H BMC Biol. 2024; 22(1):300.

PMID: 39736603 PMC: 11686917. DOI: 10.1186/s12915-024-02092-9.


Tumoroids, a valid preclinical screening platform for monitoring cancer angiogenesis.

Abbasi-Malati Z, Khanicheragh P, Narmi M, Mardi N, Khosrowshahi N, Hiradfar A Stem Cell Res Ther. 2024; 15(1):267.

PMID: 39183337 PMC: 11346257. DOI: 10.1186/s13287-024-03880-4.


Adipose Tissue in Breast Cancer Microphysiological Models to Capture Human Diversity in Preclinical Models.

Hamel K, Frazier T, Williams C, Duplessis T, Rowan B, Gimble J Int J Mol Sci. 2024; 25(5.

PMID: 38473978 PMC: 10931959. DOI: 10.3390/ijms25052728.


References
1.
Han H, Hsu S . Using 3D bioprinting to produce mini-brain. Neural Regen Res. 2017; 12(10):1595-1596. PMC: 5696831. DOI: 10.4103/1673-5374.217325. View

2.
Sharma P, Hu-Lieskovan S, Wargo J, Ribas A . Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy. Cell. 2017; 168(4):707-723. PMC: 5391692. DOI: 10.1016/j.cell.2017.01.017. View

3.
Shafi A, Schiewer M, de Leeuw R, Dylgjeri E, McCue P, Shah N . Patient-derived Models Reveal Impact of the Tumor Microenvironment on Therapeutic Response. Eur Urol Oncol. 2018; 1(4):325-337. PMC: 6241309. DOI: 10.1016/j.euo.2018.04.019. View

4.
Baker L, Tiriac H, Clevers H, Tuveson D . Modeling pancreatic cancer with organoids. Trends Cancer. 2016; 2(4):176-190. PMC: 4847151. DOI: 10.1016/j.trecan.2016.03.004. View

5.
Sung K, Yang N, Pehlke C, Keely P, Eliceiri K, Friedl A . Transition to invasion in breast cancer: a microfluidic in vitro model enables examination of spatial and temporal effects. Integr Biol (Camb). 2010; 3(4):439-50. PMC: 3094750. DOI: 10.1039/c0ib00063a. View